Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 3 (4 fluorophenyl) monomethyl glutarate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103215238A reveals a novel marine esterase PE8 for producing (R)-3-(4-fluorophenyl) monomethyl glutarate, offering a cost-effective enzymatic route for antidepressant intermediates.